52-Week Top Gaining U.S. stocks
Track U.S. stocks with the strongest price gains over the past 52 weeks on MEXC. Stocks are ranked by their 52-week percentage change to highlight leading one-year performers.

Market Overview
U.S. stocks are mixed today. The Dow Jones is -0.88%, the S&P 500 is -0.17%, and the Nasdaq Composite is +0.32%. Across individual stocks, 2,471 are advancing while 2,642 are declining, suggesting a mixed market tone.
52 Week Gainers
| # | Stock | 52 Week Range | |||||
|---|---|---|---|---|---|---|---|
| 1 | Eloxx Pharmaceuticals, Inc.ELOX | $11.60 | -0.93% | 8.23K | $46.83M | $10.87 - $23.40 | 0.00% |
| 2 | Mega Fortune Company LimitedMGRT | $130.44 | -1.36% | 721 | $1.62B | $4.04 - $170.00 | 0.00% |
| 3 | Nine Energy Service, Inc.NINE | $6.76 | -2.58% | 5.75K | $103.51M | $0.29 - $13.23 | 0.00% |
| 4 | Bank of New York Mellon CorporationBNY | $148.85 | -0.71% | 560.14K | $100.16B | $10.05 - $165.84 | 0.02% |
| 5 | SELLAS Life Sciences Group, Inc.SLS | $19.31 | +2.45% | 14.23M | $3.90B | $1.39 - $24.89 | 0.00% |
| 6 | Moderna, Inc.MRNA | $202.50 | -2.30% | 2.25M | $81.94B | $22.28 - $280.80 | 0.00% |
| 7 | agilon health, inc.AGL | $99.31 | -12.25% | 84.89K | $1.67B | $7.48 - $133.04 | 0.00% |
| 8 | Rallybio CorporationRLYB | $15.30 | +0.10% | 2.46K | $82.40M | $1.84 - $16.00 | 0.00% |
| 9 | BUUU Group LimitedBUUU | $4.38 | -11.78% | 392.91K | $1.06B | $0.61 - $8.10 | 0.00% |
| 10 | Space Exploration Technologies Corp.SPCX | $144.78 | +1.68% | 36.10M | $1.89T | $21.32 - $225.64 | 0.00% |
| 11 | Vince Holding Corp.VNCE | $12.67 | +0.08% | 38.33K | $164.00M | $1.95 - $13.90 | 0.00% |
| 12 | Kodiak Sciences Inc.KOD | $96.99 | +1.11% | 110.77K | $6.10B | $18.14 - $112.79 | 0.00% |
| 13 | New Century Logistics (BVI) LimitedNCEW | $17.25 | +5.50% | 7 | $55.20M | $3.23 - $20.83 | 0.00% |
| 14 | Climb Bio, Inc.CLYM | $9.46 | -1.79% | 78.39K | $555.90M | $1.64 - $18.33 | 0.00% |
| 15 | MindForge Inc.MF | $20.54 | -4.68% | 7.84K | $124.18M | $3.80 - $25.90 | 0.00% |
| 16 | CareDx, Inc.CDNA | $73.68 | -2.33% | 127.13K | $3.87B | $15.22 - $90.87 | 0.00% |
| 17 | AN2 Therapeutics, Inc.ANTX | $5.20 | +22.93% | 186.45K | $197.31M | $1.00 - $7.19 | 0.00% |
| 18 | Erasca, Inc.ERAS | $13.13 | -5.04% | 1.11M | $4.59B | $2.71 - $24.28 | 0.00% |
| 19 | Twist Bioscience CorporationTWST | $114.98 | +1.28% | 559.29K | $7.21B | $24.41 - $219.71 | 0.00% |
| 20 | Avita Medical, Inc.RCEL | $17.39 | +9.38% | 304.19K | $546.30M | $3.22 - $18.43 | 0.00% |
| 21 | Fossil Group, Inc.FOSL | $8.02 | -0.37% | 212.51K | $474.17M | $1.70 - $10.55 | 0.00% |
| 22 | Syntec Optics Holdings, Inc.OPTX | $6.23 | +0.99% | 128.60K | $250.94M | $1.18 - $14.92 | 0.00% |
| 23 | Spyre Therapeutics, Inc.SYRE | $95.03 | +0.85% | 249.55K | $9.02B | $23.01 - $110.64 | 0.00% |
| 24 | Q32 Bio Inc.QTTB | $8.74 | +2.49% | 108.87K | $261.68M | $1.91 - $23.57 | 0.00% |
| 25 | MaxLinear, Inc.MXL | $49.97 | -2.94% | 499.71K | $4.55B | $12.77 - $128.30 | 0.00% |
| 26 | Anterix Inc.ATEX | $79.92 | +1.71% | 31.16K | $1.57B | $19.47 - $113.00 | 0.00% |
| 27 | Eton Pharmaceutcials, Inc.ETON | $62.55 | -0.14% | 77.48K | $1.80B | $14.27 - $70.64 | 0.00% |
| 28 | 10x Genomics, Inc.TXG | $56.49 | -1.40% | 333.45K | $6.86B | $15.18 - $102.81 | 0.00% |
| 29 | AXT Inc.AXTI | $35.51 | -2.54% | 3.03M | $2.33B | $8.44 - $143.16 | 0.00% |
| 30 | Oruka Therapeutics, Inc.ORKA | $96.27 | +0.83% | 88.92K | $6.53B | $25.23 - $115.52 | 0.00% |
| 31 | Able View Global Inc.ABLV | $2.15 | -0.69% | 12.85K | $52.84M | $0.54 - $2.96 | 0.00% |
| 32 | STAK Inc.STAK | $1.74 | +3.95% | 121.27K | $29.58M | $0.29 - $12.00 | 0.00% |
| 33 | PACS Group, Inc.PACS | $47.63 | -2.25% | 146.46K | $7.56B | $14.09 - $51.68 | 0.01% |
| 34 | Veradermics, IncorporatedMANE | $124.54 | -1.21% | 109.87K | $5.47B | $32.00 - $156.63 | 0.00% |
| 35 | Entravision CommunicationEVC | $8.94 | -0.88% | 408.42K | $741.11M | $2.56 - $13.74 | 0.02% |
| 36 | Pulse Biosciences, Inc.PLSE | $44.53 | -0.11% | 45.85K | $3.28B | $12.56 - $58.94 | 0.00% |
| 37 | Tilly's Inc.TLYS | $4.14 | +1.23% | 15.07K | $96.50M | $1.14 - $6.25 | 0.00% |
| 38 | Nuvectis Pharma, Inc.NVCT | $19.66 | +3.65% | 82.75K | $676.22M | $5.77 - $29.27 | 0.00% |
| 39 | Alpha Tau Medical Ltd.DRTS | $11.86 | -0.25% | 231.18K | $1.07B | $3.43 - $15.79 | 0.00% |
| 40 | TOP Financial Group LimitedTOP | $16.99 | -0.12% | 28.60K | $2.10B | $3.06 - $17.99 | 0.00% |
| 41 | SAIHEAT LimitedSAIH | $22.83 | +5.11% | 466 | $27.29M | $5.90 - $33.00 | 0.00% |
| 42 | OmniAb, Inc.OABI | $5.10 | +0.20% | 231.37K | $743.74M | $1.35 - $5.45 | 0.00% |
| 43 | ImmunityBio, Inc.IBRX | $6.61 | +6.07% | 4.84M | $7.04B | $1.95 - $12.43 | 0.00% |
| 44 | Sandisk CorporationSNDK | $767.53 | -3.93% | 5.16M | $125.93B | $183.00 - $2,354.39 | 0.00% |
| 45 | Ultralife CorporationULBI | $15.68 | +0.06% | 24.30K | $261.27M | $4.90 - $15.83 | 0.00% |
| 46 | Iovance Biotherapeutics, Inc.IOVA | $7.48 | -2.19% | 1.72M | $3.46B | $2.08 - $15.37 | 0.00% |
| 47 | AbCellera Biologics Inc.ABCL | $11.21 | +1.31% | 623.12K | $3.66B | $2.75 - $15.02 | 0.00% |
| 48 | Micron Technology, Inc.MU | $698.77 | -1.88% | 10.31M | $790.60B | $192.59 - $1,255.00 | 0.00% |
| 49 | Turn Therapeutics Inc.TTRX | $9.02 | +3.15% | 10.16K | $285.70M | $2.57 - $16.45 | 0.00% |
| 50 | American Outdoor Brands, Inc.AOUT | $19.49 | +1.86% | 26.11K | $245.99M | $6.26 - $19.60 | 0.00% |
Trade U.S. stocks Your Way on MEXC
| RealStocks | Tokenized Stocks | Stock Futures | |
|---|---|---|---|
| What it is | RealStocks — real shares of U.S.-listed companies | Blockchain-based tokens linked to U.S. stocks/ETFs | USDT-margined futures on U.S. stock price movements |
| Ownership | Yes — actual shares | No — synthetic exposure only | No — derivative exposure only |
| Shareholder rights | Yes (e.g. dividends) | No | No |
| Trading hours | U.S. market sessions (pre-market, regular, after-hours, overnight) | 24/7 | Up to 24/7 (supported pairs) |
| Position types | Buy and hold | Buy and hold | Long, short, leveraged |
| Best for | Long-term investors seeking ownership and dividend income | Traders wanting round-the-clock access to stock exposure without holding shares | Active/short-term traders looking to speculate or hedge with leverage |
Why Trade U.S. stocks on MEXC?
RealStocks, Real Ownership
Buy real US-listed shares through MEXC's partner licensed broker and receive applicable shareholder benefits, including dividends.
7,000+ U.S. stocks & ETFs
Access 7,000+ US-listed stocks and ETFs across technology, finance, healthcare, consumer sectors, and more.
Seamless USDT-to-Stock Access
Transfer USDT and convert between USDT and USD to fund your RealStocks account with ease.
Lower-Cost Stock Trading
Trade real U.S. stocks with competitive costs and keep more capital available for your investment strategy.
Frequently Asked Questions (FAQ)
What are 52-week top gaining U.S. stocks?
How is the 52-week gain calculated?
Which stock has gained the most over 52 weeks?
Why use a 52-week stock performance ranking?
Does strong 52-week performance guarantee future gains?
How is this different from the daily Top Gainers list?
Discover Top US Stocks
Disclaimer
US stock prices, indices, rankings, charts, and other market data displayed on this page may be sourced from third-party providers and may be delayed or inaccurate. MEXC provides this information for informational and educational purposes only and does not guarantee its accuracy or completeness. Nothing on this page constitutes financial or investment advice or a recommendation to buy or sell any security. US stock trading involves risk, and past performance does not guarantee future results. Users should conduct independent research before making investment decisions.






.b39e813829fa.png)

.b39e815d234d.png)
.b39e81c62f33.png)
.b39e81f7d220.png)
